High Resolution Micro OCT Imaging
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Aug 18, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "High Resolution Micro OCT Imaging," is looking at a special type of imaging technology to create detailed pictures of the lungs and nose. Researchers hope that by understanding how this imaging works, they can develop better treatments for patients with conditions like cystic fibrosis, chronic obstructive pulmonary disease (COPD), primary ciliary dyskinesia (PCD), COVID-19, and sinusitis.
To participate in the study, you need to be over 14 years old and either have cystic fibrosis or be a healthy individual without respiratory issues. It's important to note that if you've had a recent respiratory infection or major sinus surgery, you may not be eligible. Participants will undergo imaging procedures, and the study is currently recruiting individuals of all genders. This research aims to improve diagnosis and treatment options for patients in the future, making it an exciting opportunity for those who qualify.
Gender
ALL
Eligibility criteria
- THE INCLUSION CRITERIA:
- • Patients diagnosed with CF or healthy normal controls with no respiratory disease
- • Patients must be over the age of 14
- • Patient must be able to give informed consent
- THE EXCLUSION CRITERIA:
- • Patients with recent respiratory infection requiring antibiotics or corticosteroids in the last 4 weeks (excluding routine perioperative antibiotics)
- • Patients with major sinus surgery that will alter the nasal anatomy and preclude imaging of the nares
- • Any condition that in the opinion of the investigator will alter the safety of pilot testing in the operating room
- • Female subjects who are pregnant
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Steven M Rowe
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials